- Report
- August 2023
- 51 Pages
United States
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Italy
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
China
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Netherlands
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Germany
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
France
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Brazil
From €552EUR$600USD£469GBP
- Report
- August 2023
- 180 Pages
Global
From €3447EUR$3,750USD£2,931GBP
- Report
- July 2023
- 100 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Drug Pipelines
- April 2023
- 34 Pages
Global
From €9188EUR$9,995USD£7,812GBP
- Report
- October 2022
- 68 Pages
Global
- Report
- September 2022
Global
€4990EUR$5,815USD£4,391GBP
- Report
- September 2022
- 240 Pages
Global
From €5102EUR$5,550USD£4,338GBP
- Report
- June 2022
- 220 Pages
Global
From €3171EUR$3,450USD£2,696GBP
- Report
- December 2021
- 353 Pages
Global
From €5056EUR$5,500USD£4,299GBP
- Report
- November 2021
- 106 Pages
Global
From €4550EUR$4,950USD£3,869GBP
- Report
- October 2021
- 210 Pages
Global
From €3447EUR$3,750USD£2,931GBP
- Report
- November 2020
- 450 Pages
Global
From €4504EUR$4,900USD£3,830GBP
- Report
- September 2020
- 700 Pages
Global
From €4504EUR$4,900USD£3,830GBP
- Drug Pipelines
- July 2020
- 33 Pages
Global
From €3217EUR$3,500USD£2,735GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more